beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria
- PMID: 1778852
- DOI: 10.1093/jac/28.2.209
beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria
Abstract
Twenty-five strains of Enterobacteriaceae (five each of Enterobacter cloacae, Citrobacter freundii, Serratia marcescens, Morganella morganii, and Providencia stuartii) and five strains of Pseudomonas aeruginosa were exposed to various concentrations of cefpirome or ceftazidime in agar. Mutants with a greater than four-fold increase in the MIC were examined for changes in beta-lactamase expression and outer membrane protein (OMP) profile. Both agents selected mutants with decreased susceptibility to the selecting antibiotic and other beta-lactams at a frequency of 10(-7)-10(-8). The MICs of all beta-lactams were higher for the resistant mutants of E. cloacae and P. aeruginosa than for the other species. Both agents selected mutants expressing derepressed class I beta-lactamase, but this was more common with ceftazidime. Only a few mutants of P. aeruginosa and E. cloacae had an MIC of cefpirome that was above the recommended breakpoint concentration. Some mutant strains of Enterobacteriaceae lacked an OMP of molecular size similar to OmpF, but the MIC of cefpirome was below the breakpoint concentration for all these strains.
Similar articles
-
Selection and characterization of cefepime-resistant gram-negative bacteria.J Antimicrob Chemother. 1991 Nov;28(5):669-76. doi: 10.1093/jac/28.5.669. J Antimicrob Chemother. 1991. PMID: 1778870
-
A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.J Antimicrob Chemother. 1990 Dec;26(6):749-62. doi: 10.1093/jac/26.6.749. J Antimicrob Chemother. 1990. PMID: 2081717
-
In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.Antimicrob Agents Chemother. 1999 Aug;43(8):1895-900. doi: 10.1128/AAC.43.8.1895. Antimicrob Agents Chemother. 1999. PMID: 10428909 Free PMC article.
-
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.Diagn Microbiol Infect Dis. 1998 Jul;31(3):461-6. doi: 10.1016/s0732-8893(98)00029-7. Diagn Microbiol Infect Dis. 1998. PMID: 9635237 Review.
-
Selection of beta-lactamase producers during cephalosporin and penicillin therapy.Scand J Infect Dis Suppl. 1986;49:100-5. Scand J Infect Dis Suppl. 1986. PMID: 3103207 Review.
Cited by
-
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.Drugs. 1997 Jul;54(1):117-40. doi: 10.2165/00003495-199754010-00013. Drugs. 1997. PMID: 9211085 Review.
-
Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.Antimicrob Agents Chemother. 1995 Feb;39(2):386-93. doi: 10.1128/AAC.39.2.386. Antimicrob Agents Chemother. 1995. PMID: 7726503 Free PMC article.
-
TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.Antimicrob Agents Chemother. 2000 Apr;44(4):997-1003. doi: 10.1128/AAC.44.4.997-1003.2000. Antimicrob Agents Chemother. 2000. PMID: 10722503 Free PMC article.
-
Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins.Antimicrob Agents Chemother. 1996 May;40(5):1289-93. doi: 10.1128/AAC.40.5.1289. Antimicrob Agents Chemother. 1996. PMID: 8723487 Free PMC article.
-
Differentially expressed outer membrane proteins of Vibrio alginolyticus in response to six types of antibiotics.Mar Biotechnol (NY). 2010 Nov;12(6):686-95. doi: 10.1007/s10126-009-9256-4. Epub 2010 Mar 9. Mar Biotechnol (NY). 2010. PMID: 20217167
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources